Dundee researchers have received a grant from JDRF, the leading global type 1 diabetes (T1D) research and advocacy organisation, to support a clinical trial that could potentially advance new life-saving treatment for people with T1D and heart failure.
University of Dundee research has helped explain why a commonly used antibiotic can lead to an increased risk of heart attacks, opening up the possibility of precision prescribing based on a patient’s genes.